M&A Unbound – Will pent-up demand drive deal flow in Q4?

M&A Unbound – Will pent-up demand drive deal flow in Q4?

In partnership with:

Sylvester Oppong, head of healthcare services M&A, EY

Paolo Pieri, chief executive, Circle Health

James Reed, partner, DAC Beachcroft

The Covid-19 pandemic paused much of the corporate activity in the sector, outside of emergency preparations and workforce adaptation. However, as the world continues to adapt to this ‘new normal’ there will be opportunities and necessities for businesses to further protect their position or seek investments in core or complementary businesses to improve their market position.

Discover unparalleled expert thinking, with the continuation of HealthInvestor UK’s webinar series, join the in-depth panel discussion, focusing on the state of the M&A marketplace, held in association with the healthcare team at DAC Beachcroft.

Chaired by Investor Publishing’s managing director Vernon Baxter and featuring the chief executive of Circle Health, Paolo Pieri, the new head of healthcare services M&A at EY – Sylvester Oppong and James Reed – a partner in the corporate team at DAC Beachcroft – the panel discuss the opportunities in the health and social care sector against a backdrop of restructurings and recalibration.

Key points of discussion:
>Transactions – How will due diligence questionschange in response to Covid-19 and what impact will this have on the deal process?
> Distressed opportunities – Will we see buy and build strategies in certain sub-sectors coming out of the crisis?
> Backlog management – What effects will an increased demand for non-urgent healthcare have on independent health businesses?
> Contract adaptation – How will restructuring current arrangements impact contracts with external suppliers?